**Menopause Hormone Therapy Not Linked to Dementia Risk** According to a recent review of over one million women's health data, menopause hormone therapy (MHT) is not associated with an increased risk of dementia.
**Menopause Hormone Therapy Not Linked to Dementia Risk**According to a recent review of over one million women's health data, menopause hormone therapy (MHT) is not associated with an increased risk of dementia. This new analysis provides a significant shift in the understanding of MHT and its effects on cognitive decline.
Menopause hormone therapy, previously known as hormone replacement therapy (HRT), is used to alleviate symptoms of menopause. For decades, women have been cautioned about potential risks, including cardiovascular disease, cancer, and dementia. However, evidence suggests that some of these concerns were overstated.
Recently, the FDA removed its black box warning labels on MHT products, citing a return to evidence-based medicine and giving women control over their health again. This change reflects the growing body of research indicating that MHT neither raises nor lowers dementia risk.
**A New Era for Menopause Hormone Therapy**A new meta-analysis commissioned by the World Health Organization (WHO) found no link between MHT and dementia risk. The study, published in The Lancet Healthy Longevity, provides crucial guidance for women, clinicians, and policymakers. According to Melissa Melville, PhD Candidate and Ageing Researcher at University College London, "Our work will help inform upcoming WHO guidelines on reducing the risk of cognitive decline and dementia."
Melville emphasizes that decisions about MHT should focus on symptom relief and quality of life, rather than fear of cognitive decline. Clinicians and patients can now rely on evidence-based information to make informed choices about menopause hormone therapy.
**The Complex History of Menopause Hormone Therapy**The history of MHT is marked by controversy and complexity. The practice began in the 1960s and peaked in the United States in the 1990s. However, a landmark study in 2002 suggested that the risks outweighed the benefits, leading to a significant decline in MHT use.
Subsequent research has continued to shape our understanding of MHT's effects on cognitive health. While some studies have raised concerns about dementia risk, others have found no association. The latest analysis provides a critical update on this complex topic and offers new hope for women seeking symptom relief during menopause.
Learn more about hair transplant at Rubenhair clinic.
Get a Free Consultation
Consult with our specialists about FUE procedure, PRP therapy or hair transplant.
